736 related articles for article (PubMed ID: 26129705)
1. Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication-Overuse Headache.
Lucchesi C; Baldacci F; Cafalli M; Chico L; Lo Gerfo A; Bonuccelli U; Siciliano G; Gori S
Headache; 2015; 55(7):984-91. PubMed ID: 26129705
[TBL] [Abstract][Full Text] [Related]
2. Plasma Levels of Oxidative Stress Markers, before and after
Dini E; Mazzucchi S; De Luca C; Cafalli M; Chico L; Lo Gerfo A; Siciliano G; Bonuccelli U; Baldacci F; Gori S
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31635021
[TBL] [Abstract][Full Text] [Related]
3. Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine.
Vieira DS; Naffah-Mazzacoratti Mda G; Zukerman E; Senne Soares CA; Cavalheiro EA; Peres MF
Headache; 2007 Jun; 47(6):842-7. PubMed ID: 17578532
[TBL] [Abstract][Full Text] [Related]
4. Association of RAMP1 rs7590387 with the risk of migraine transformation into medication overuse headache.
Cargnin S; Pautasso C; Viana M; Sances G; Mittino D; Cantello R; Tassorelli C; Nappi G; Terrazzino S
Headache; 2015 May; 55(5):658-68. PubMed ID: 25881990
[TBL] [Abstract][Full Text] [Related]
5. [Frovatriptan possibly causing acute myocardial infarction].
Møller-Helgestad OK; Kaltoft AK; Kasch H
Ugeskr Laeger; 2015 Mar; 177(13):V10140537. PubMed ID: 25822816
[TBL] [Abstract][Full Text] [Related]
6. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
Lipton RB; Serrano D; Nicholson RA; Buse DC; Runken MC; Reed ML
Headache; 2013; 53(10):1548-63. PubMed ID: 23992516
[TBL] [Abstract][Full Text] [Related]
7. Increased cerebral responses to salient transitions between alternating stimuli in chronic migraine with medication overuse headache and during migraine attacks.
Bogdanov VB; Bogdanova OV; Viganò A; Noirhomme Q; Laureys S; Dallel R; Phillips C; Schoenen J
Cephalalgia; 2019 Jul; 39(8):988-999. PubMed ID: 30786732
[TBL] [Abstract][Full Text] [Related]
8. Similarities and differences between chronic migraine and episodic migraine.
Ferrari A; Leone S; Vergoni AV; Bertolini A; Sances G; Coccia CP; Ottani A; Pinetti D; Sternieri E
Headache; 2007 Jan; 47(1):65-72. PubMed ID: 17355496
[TBL] [Abstract][Full Text] [Related]
9. [Self-medication of regular headache: a community pharmacy-based survey in Belgium].
Mehuys E; Paemeleire K; Van Hees T; Christiaens T; Van Bortel L; Van Tongelen I; Philippe G; Prévôt ML; Evrard B; Piette M; De Bolle L; Remon JP; Boussery K
J Pharm Belg; 2012 Jun; (2):4-10. PubMed ID: 22978009
[TBL] [Abstract][Full Text] [Related]
10. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and mechanisms of chronic migraine and medication-overuse headache].
Takeshima T
Rinsho Shinkeigaku; 2010 Nov; 50(11):990-3. PubMed ID: 21921539
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.
Schwedt TJ; Alam A; Reed ML; Fanning KM; Munjal S; Buse DC; Dodick DW; Lipton RB
J Headache Pain; 2018 May; 19(1):38. PubMed ID: 29797100
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A and acute drug costs in migraine with triptan overuse.
Christie SN; Giammarco R; Gawel M; Mackie G; Gladstone J; Becker WJ
Can J Neurol Sci; 2010 Sep; 37(5):588-94. PubMed ID: 21059503
[TBL] [Abstract][Full Text] [Related]
14. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G
Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472
[TBL] [Abstract][Full Text] [Related]
15. Overuse of paracetamol caffeine aspirin powders affects cerebral glucose metabolism in chronic migraine patients.
Di W; Shi X; Zhu Y; Tao Y; Qi W; Luo N; Xiao Z; Yi C; Miao J; Zhang A; Zhang X; Fang Y
Eur J Neurol; 2013 Apr; 20(4):655-62. PubMed ID: 23114018
[TBL] [Abstract][Full Text] [Related]
16. Mindfulness and pharmacological prophylaxis have comparable effect on biomarkers of inflammation and clinical indexes in chronic migraine with medication overuse: results at 12 months after withdrawal.
Grazzi L; D'Amico D; Raggi A; Leonardi M; Ciusani E; Corsini E; D'Andrea G; Bolner A; Salgado-García F; Andrasik F; Sansone E
Neurol Sci; 2017 May; 38(Suppl 1):173-175. PubMed ID: 28527073
[TBL] [Abstract][Full Text] [Related]
17. Analysis of leukocytes in medication-overuse headache, chronic migraine, and episodic migraine.
Forcelini CM; Dantas DC; Luz C; Santin R; Stein AT; Barros HM; Barea LM
Headache; 2011 Sep; 51(8):1228-38. PubMed ID: 21649652
[TBL] [Abstract][Full Text] [Related]
18. Degradation of endocannabinoids in chronic migraine and medication overuse headache.
Cupini LM; Costa C; Sarchielli P; Bari M; Battista N; Eusebi P; Calabresi P; Maccarrone M
Neurobiol Dis; 2008 May; 30(2):186-9. PubMed ID: 18358734
[TBL] [Abstract][Full Text] [Related]
19. Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients.
Ferrari A; Savino G; Gallesi D; Pinetti D; Bertolini A; Sances G; Coccia CP; Pasciullo G; Leone S; Loi M; Sternieri E
Pharmacol Res; 2006 Aug; 54(2):142-9. PubMed ID: 16697657
[TBL] [Abstract][Full Text] [Related]
20. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
